RecruitingPrimary Sjogren's Disease
Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease
Eligible age
18–75 yrs
Accepts
All genders
Locations
16 states
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease (UPSTREAM SjD)
Sponsor: Vor Biopharma
You may qualify if…
- ✓ 1. Male or female aged 18 to 75 years of age (both inclusive) at screening
- ✓ 2. Participants must meet the 2016 American College of Rheumatology (ACR)/EULAR classification criteria for primary Sjogren's Syndrome at the time of screening.
- ✓ 3. ESSDAI ≥5 at screening (score calculated excluding renal, pulmonary and neurological domains)
- ✓ 4. Participants are seropositive for antibodies to Sjogren's Syndrome A (SSA)/Anti-Sjogren's Syndrome A (Ro) at the Screening Visit.
- ✓ Additional inclusion criteria are defined in the protocol
You may not qualify if…
- ✕ 1. Participants who have a systemic autoimmune disease other than Primary Sjogren's Disease, such as rheumatoid arthritis, systemic lupus erythematosus, or systemic sclerosis, that can better explain the majority of the symptoms (i.e., secondary Sjogren's Disease)
- ✕ 2. Participants who have another autoimmune disease or inflammatory condition that could interfere with assessment of response of Primary Sjogren's Disease to therapy (e.g., systemic sclerosis, inflammatory bowel disease, gout).
- ✕ 3. Participants with severe fibromyalgia that could interfere with the assessment of response of Primary Sjogren's Disease to therapy
- ✕ 4. Active life-threatening or organ-threatening complications of Primary Sjogren's Disease at the time of screening based on investigator evaluation
- ✕ 5. Significant, uncontrolled medical disease in any organ system not related to Primary Sjogren's Disease (e.g., poorly controlled asthma, cardiovascular disease, accelerated hypertension, major depression, etc.) that in the opinion of the investigator would preclude participant participation.
- ✕ Additional exclusion criteria are defined in the protocol
Where it's recruiting
Arizona
Chandler · Flagstaff · Glendale · Phoenix …
California
Beverly Hills
Colorado
Denver · Fort Collins · Tampa
Florida
Clearwater · Cooper City · Green Acres · Miami …
Idaho
Boise
Illinois
Chicago · Schaumburg · Willowbrook
Louisiana
Lake Charles
Maryland
Rockville
Massachusetts
Boston
Michigan
Saint Clair Shores
Missouri
Kansas City
North Carolina
Charlotte · Durham
Source: ClinicalTrials.gov · NCT07404865 · last updated 2026-10-19